PhotoCure ASA is a Norway-based business group associated with the research, development, production, distribution, marketing, and sales of pharmaceutical products and specialty pharmaceutical companies... Show more
PHCUF's Aroon Indicator triggered a bullish signal on July 18, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 110 similar instances where the Aroon Indicator showed a similar pattern. In of the 110 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .
The Momentum Indicator moved above the 0 level on July 08, 2025. You may want to consider a long position or call options on PHCUF as a result. In of 19 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for PHCUF just turned positive on July 09, 2025. Looking at past instances where PHCUF's MACD turned positive, the stock continued to rise in of 19 cases over the following month. The odds of a continued upward trend are .
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 13 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 11 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
PHCUF broke above its upper Bollinger Band on July 14, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PHCUF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.883) is normal, around the industry mean (62.701). PHCUF has a moderately high P/E Ratio (500.000) as compared to the industry average of (88.783). PHCUF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.913). Dividend Yield (0.000) settles around the average of (0.122) among similar stocks. P/S Ratio (3.158) is also within normal values, averaging (18.372).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PHCUF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.
Industry PharmaceuticalsOther
A.I.dvisor indicates that over the last year, PHCUF has been loosely correlated with HLTRF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if PHCUF jumps, then HLTRF could also see price increases.
Ticker / NAME | Correlation To PHCUF | 1D Price Change % | ||
---|---|---|---|---|
PHCUF | 100% | N/A | ||
HLTRF - PHCUF | 38% Loosely correlated | -0.83% | ||
INCR - PHCUF | 26% Poorly correlated | +0.65% | ||
ELAN - PHCUF | 24% Poorly correlated | +1.57% | ||
MKKGY - PHCUF | 22% Poorly correlated | -0.52% | ||
CRYM - PHCUF | 20% Poorly correlated | N/A | ||
More |